Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Antibiotics neomycin

The method contains three stages including first establishing a cell line followed by test chemical exposure and finally evaluated for expression of cell surface markers. To establish a cell line, human leukocyte preparations are attained from a plasma distributor. The leukocyte preparations as described by Ryan et al. (2004), are diluted with an equal part of complete medium (RPMI 1640 containing 1 x L-glutamine, 1 x penicillin-streptomycin-neomycin antibiotic mixture), 30 p,2-mercaptoethanol and 10 % heat inactivated fetal bovine serum. The diluted preparation is layered onto a Ficoll-Paque gradient to... [Pg.319]

Schillings, R. T., and C. P. Schaffner Differentiation of catenulin-neomycin antibiotics. Identy of catenulin, paromomycin, hydroxymycin, and aminosidin. Antimicrobial Agents and Chemotherapy 274 (196I). [Pg.371]

ScHiMBOR, R. F. The microbiological incorporation of labeled intermediates into the neomycin antibiotics. Ph. D. Thesis, University of Illinois, December 1965. [Pg.371]

Pharmaceutical. Ion-exchange resins are useful in both the production of pharmaceuticals (qv) and the oral adrninistration of medicine (32). Antibiotics (qv), such as streptomycin [57-92-17, neomycin [1404-04-2] (33), and cephalosporin C [61-24-5] (34), which are produced by fermentation, are recovered, concentrated, and purified by adsorption on ion-exchange resins, or polymeric adsorbents. Impurities are removed from other types of pharmaceutical products in a similar manner. Resins serve as catalysts in the manufacture of intermediate chemicals. [Pg.387]

A Acetylation, O-Phosphorylation, and O-Adenylylation. A/-Acetylation, O-phosphorjiation, and O-adenyljiation provide mechanisms by which therapeutically valuable aminocyclitol antibiotics, eg, kanamycia [8063-07-8] gentamicin [1403-66-3] sisomicin [32385-11-8], streptomycia [57-92-1], neomycin, or spectinomycin are rendered either partially or completely iaactive. Thus, eg, kanamycia B [4696-78-8] (50) can be iaactivated by modification at several sites, as shown. The elucidation of these mechanisms has allowed chemical modification of the sites at which the iaactivation occurs. Several such bioactive analogues, eg, dibekacia and amikacin have been prepared and are not subject to the iaactivation hence, they inhibit those organisms against which the parent antibiotics are iaeffective (96) (see Antibacterial agents, synthetic). [Pg.314]

In 1939 the isolation of a mixture of microbial products named tyrotbricin from a soil bacillus was described. Further investigation showed this material to be a mixture of gramicidin and tyrocidine. In rapid succession the isolation of actinomycin (1940), streptothricin (1942), streptomycin (1943), and neomycin (1949), produced by Streptomjces were reported and in 1942 the word antibiotic was introduced. Chloramphenicol, the first of the so-called broad spectmm antibiotics having a wide range of antimicrobial activity, was discovered in 1947. Aureomycin, the first member of the commercially important tetracycline antibiotics, was discovered in 1948. [Pg.473]

Aminoglycosides. Antibiotics ia the amiaoglycoside group characteristically contain amino sugars and deoxystreptamiae or streptamiae. This family of antibiotics has frequentiy been referred to as aminocyclitol amiaoglycosides. Representative members are streptomycia, neomycin, kanamycia, gentamicin, tobramycia, and amikacin. These antibiotics all inhibit proteia biosynthesis. [Pg.474]

Nystatin (100,000 lU) is also available in combination with neomycin sulfate [1405-10-3] (35,000 lU), polymyxin B sulfate [1405-20-5] (35,000 lU), acetarsol [97-44-9] (150 mg), and dimethicone [8050-81-5] (2,500 mg). One or two ovules per day are inserted vaginaHy for at least 6—12 days. This combination has an antibacterial, antimycotic, and antitrichomonas action (see also Antibiotics, oligosaccharides Antiparasitic agents, antiprotozoals). [Pg.252]

Amphotericin B. Amphotericin B (3), an important polyene antibiotic, is administered almost exclusively via the intravenous route and is therefore discussed in more detail under the systemic antimycotics. The vaginal tablets contain 50 mg amphotericin B, and 100 mg tetracycline base per tablet (see also Antibiotics, tetracyclines). The tablets for oral use contain 50 mg amphotericin B, 250 mg tetracycline base, and 125 mg sodium hexametaphosphate. A combination ointment contains 1 mg fludrocortisone acetate, 2.5 mg neomycin, 0.25 mg gramicidin, and 1 g plastibase in addition to 30 mg amphotericin B (see also Antibiotics, peptides). [Pg.252]

By this approach, a wide variety of structural analogues of 2-deoxystreptamine have been used to produce a range of neomycin-like antibiotics. These structural analogues include methylated and halogenated derivatives of 2-deoxystreptamine. [Pg.184]

Topical antibiotics exert a direct local effect on specific microorganisms and may be bactericidal or bacteriostatic. Bacitracin (Baciguent) inhibits the cell wall synthesis. Bacitracin, gentamicin (G-myticin), erythromycin (Emgel), and neomycin are examples of topical antibiotics. These drugp are used to prevent superficial infections in minor cuts, wounds, skin abrasions, and minor burns. Erythromycin is also indicated for treatment of acne vulgaris. [Pg.603]

Co-administration of ofloxacin and chitosan in eyedrops increased the bioavailabUity of the antibiotic [290]. Trimethyl chitosan was more effective because of its solubility (plain chitosan precipitates at the pH of the tear fluid). On the other hand, N-carboxymethyl chitosan did not enhance the corneal permeability nevertheless it mediated zero-order ofloxacin absorption, leading to a time-constant effective antibiotic concentration [291]. Also W,0-carboxymethyl chitosan is suitable as an excipient in ophthalmic formulations to improve the retention and the bioavailability of drugs such as pilocarpine, timolol maleate, neomycin sulfate, and ephedrine. Most of the drugs are sensitive to pH, and the composition should have an acidic pH, to enhance stability of the drug. The delivery should be made through an anion exchange resin that adjusts the pH at around 7 [292]. Chitosan solutions do not lend themselves to thermal sterilization. A chitosan suspension, however. [Pg.190]

Intravenous antibiotic administration is the most common delivery method for surgical prophylaxis. Intravenous administration ensures complete bioavailability while minimizing the impact of patient-specific variables. Oral administration is also used in some bowel operations. Non-absorbable compounds like erythromycin base and neomycin are given up to 24 hours prior to surgery to cleanse the bowel. Note that oral agents are used adjunctively and do not replace IV agents. [Pg.1234]

Two studies compared the effect of rifaximin to that of neomycin and/or of rifampicin [72, 73] on the fecal flora in rats. In the first study [72] the antibiotic (1, 10, 30 and 100 mg/kg orally for 7 days) did inhibit both aerobic (especially coliforms and cocci) and anaerobic bacterial growth. Its activity was similar to that of neomycin and stronger than that of rifampicin. In the second investigation [73] the antibiotic effect on aerobic microorganisms was specifically investigated. Oral rifaximin treatment (50 mg/kg for 3 days) caused a marked reduction in the number of total aerobic bacteria and salmonellae, while neomycin led only to a decrease in salmonella counts, but did not cause statistically significant changes in the total aerobic bacterial population. [Pg.42]

Development of resistance to rifaximin is primarily due to a chromosomal one-step alteration in the drug target, DNA-dependent RNA polymerase. This differs from the plasmid-mediated resistance commonly acquired by bacteria to aminoglycoside antibiotics such as neomycin... [Pg.71]

Haltalin KC, Nelson JD, Hinton LV, Kusmiesz HT, Sladoje M Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis. A double-blind study with ampicillin and neomycin. J Pediatr 1968 72 708-720. [Pg.80]


See other pages where Antibiotics neomycin is mentioned: [Pg.292]    [Pg.802]    [Pg.617]    [Pg.371]    [Pg.292]    [Pg.802]    [Pg.617]    [Pg.371]    [Pg.178]    [Pg.183]    [Pg.252]    [Pg.475]    [Pg.483]    [Pg.486]    [Pg.403]    [Pg.146]    [Pg.161]    [Pg.302]    [Pg.1087]    [Pg.617]    [Pg.106]    [Pg.430]    [Pg.655]    [Pg.703]    [Pg.703]    [Pg.75]    [Pg.177]    [Pg.206]    [Pg.424]    [Pg.188]    [Pg.189]    [Pg.322]    [Pg.31]    [Pg.38]    [Pg.41]    [Pg.50]    [Pg.51]    [Pg.60]   


SEARCH



Aminoglycoside antibiotics Neomycin Streptomycin

Antibiotic agents neomycin

Antibiotics Used Topically with Emphasis on Neomycin and Bacitracin

Neomycin aminoglycoside antibiotics

Neomycin antibiotic resistance markers

Neomycin antibiotics development

Neomycine

© 2024 chempedia.info